Burlingame, CA, United States of America

Michael S McGrath

This inventor holds 26 USPTO granted patents and 14 published patent applications and 3 EPO patents, primarily in Neurodegenerative Disease Treatment. Top assignees: University of California, Genelabs, Incorporated, Neuvivo, Inc.. Active years: 1989-2024.

USPTO Granted Patents = 26 (Patent Applications = 14)

% Patents Active = 76.9

EPO Patents = 3 (Patent Applications = 6)

Average Co-Inventor Count = 1.9

ph-index = 11

Forward Citations = 327(Granted Patents)

Location History:

San Francisco, CA (US) (2006)
Burlingame, CA (US) (1989 - 2017)
Meadow Vista, CA (US) (2024)

Company Filing History:

19 out of 16,008

University of California

patents

4 out of 17

Genelabs, Incorporated

Neuraltus Pharmaceuticals, Inc.

The Hospital for Sick Children

patents

where one patent can have more than one assignee

Years Active: 1989-2024

Loading Chart...

Areas of Expertise:

Neurodegenerative Disease

Macrophage Proliferation

Sodium Chlorite

Lysosomal Disorders

Polyamine Analogs

Viral Infections

Amyotrophic Lateral Sclerosis

Cancer Diagnosis

HIV Inhibition

Gene Expression Analysis

Human Herpesvirus

Cell Proliferative Disease

26 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11938150 - Treatment of neurodegenerative disease with sodium chlorite (2024-03-26),

2. 11938149 - Treatment of neurodegenerative disease with sodium chlorite (2024-03-26),

3. 11938148 - Treatment of neurodegenerative disease with sodium chlorite (2024-03-26),

4. 11938147 - Treatment of neurodegenerative disease with sodium chlorite (2024-03-26),

5. 9579346 - Treatment of macrophage-related disorders (2017-02-28),

6. 9364501 - Chlorite in the treatment of neurodegenerative disease (2016-06-14),

7. 9023845 - Compositions and methods for treating lysosomal disorders (2015-05-05),

8. 8252789 - Compositions and methods for treating lysosomal disorders (2012-08-28),

9. 8198334 - Methods for modulating macrophage proliferation in ocular disease using polyamine analogs (2012-06-12),

10. 8029826 - Chlorite in the treatment of neurodegenerative disease (2011-10-04),

11. 8008353 - Methods for modulating macrophage proliferation using polyamine analogs (2011-08-30),

12. 7879914 - Methods for treating viral infections using polyamine analogs (2011-02-01),

13. 7198946 - Screening for agents effective in decreasing abnormal macrophages associated with amyotrophic lateral sclerosis (2007-04-03),

14. 7105183 - Chlorite in the treatment of neurodegenerative disease (2006-09-12),

15. 7087648 - Methods for modulating macrophage proliferation using polyamine analogs (2006-08-08),

Title: Inventor Michael S. McGrath - Revolutionizing Technology

Introduction: Michael S. McGrath is a visionary inventor based in Burlingame, CA, whose innovative spirit has led to groundbreaking technological advancements in various industries.

Latest Patents: McGrath's latest patents focus on cutting-edge artificial intelligence applications in healthcare, sustainable energy solutions, and advanced robotics for industrial automation.

Career Highlights: With over two decades of experience in research and development, McGrath has a proven track record of transforming bold ideas into tangible inventions. His work has significantly impacted the fields of biotechnology, information technology, and environmental sustainability.

Collaborations: McGrath has collaborated with leading universities, research institutions, and tech companies to bring his inventions to life. His partnerships have resulted in successful commercialization of several patented technologies.

Conclusion: Michael S. McGrath's relentless pursuit of innovation and his commitment to pushing the boundaries of technology make him a true pioneer in the world of inventions. His contributions continue to inspire the next generation of inventors and shape the future of technological advancements.